2022 Q1 Form 10-Q Financial Statement
#000035501922000024 Filed on May 16, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q2 | 2021 Q1 |
---|---|---|---|
Revenue | $24.57M | $24.70M | $23.09M |
YoY Change | 6.41% | 18.67% | 10491.74% |
Cost Of Revenue | $12.51M | $12.54M | $12.44M |
YoY Change | 0.57% | 42.14% | 9.99% |
Gross Profit | $12.06M | $12.16M | $10.66M |
YoY Change | 13.13% | 1.41% | 2.8% |
Gross Profit Margin | 49.08% | 49.23% | 46.17% |
Selling, General & Admin | $6.068M | $7.922M | $6.114M |
YoY Change | -0.75% | -28.18% | -15.37% |
% of Gross Profit | 50.32% | 65.16% | 57.35% |
Research & Development | $354.0K | $393.0K | $419.0K |
YoY Change | -15.51% | -10.69% | -21.68% |
% of Gross Profit | 2.94% | 3.23% | 3.93% |
Depreciation & Amortization | $1.185M | $981.7K | $1.090M |
YoY Change | 8.72% | 7.88% | 9.22% |
% of Gross Profit | 9.83% | 8.07% | 10.23% |
Operating Expenses | $6.422M | $8.315M | $6.533M |
YoY Change | -1.7% | -27.44% | -15.8% |
Operating Profit | $5.638M | $3.844M | $4.127M |
YoY Change | 36.61% | 625.21% | 58.06% |
Interest Expense | $89.00K | -$130.7K | $19.00K |
YoY Change | 368.42% | -286.77% | 11.76% |
% of Operating Profit | 1.58% | -3.4% | 0.46% |
Other Income/Expense, Net | $500.4K | $144.0K | |
YoY Change | 614.93% | ||
Pretax Income | $5.727M | $4.213M | $4.311M |
YoY Change | 32.85% | 528.86% | 58.26% |
Income Tax | $2.465M | $2.018M | $12.00K |
% Of Pretax Income | 43.04% | 47.88% | 0.28% |
Net Earnings | $2.291M | $720.6K | $3.868M |
YoY Change | -40.77% | 24.24% | 206.74% |
Net Earnings / Revenue | 9.32% | 2.92% | 16.75% |
Basic Earnings Per Share | $0.33 | $0.55 | |
Diluted Earnings Per Share | $0.32 | $102.0K | $0.54 |
COMMON SHARES | |||
Basic Shares Outstanding | 6.554M shares | 6.554M shares | |
Diluted Shares Outstanding | 6.682M shares | 6.682M shares |
Balance Sheet
Concept | 2022 Q1 | 2021 Q2 | 2021 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $46.04M | $44.49M | $40.80M |
YoY Change | 12.85% | 20.9% | 31.19% |
Cash & Equivalents | $46.01M | $44.46M | $40.81M |
Short-Term Investments | $32.00K | $32.18K | $0.00 |
Other Short-Term Assets | $1.095M | $1.227M | $1.300M |
YoY Change | -15.77% | -31.81% | -27.78% |
Inventory | $2.368M | $1.663M | $2.200M |
Prepaid Expenses | |||
Receivables | $64.83M | $61.20M | $59.20M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $114.3M | $108.6M | $103.6M |
YoY Change | 10.39% | 13.24% | 13.37% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $22.44M | $21.85M | $22.13M |
YoY Change | 1.39% | 2.27% | 4.12% |
Goodwill | $4.269M | $4.269M | $283.9K |
YoY Change | 1403.8% | 7.12% | -92.88% |
Intangibles | $3.770M | $4.038M | $4.090M |
YoY Change | -7.82% | -1.73% | -1.73% |
Long-Term Investments | |||
YoY Change | |||
Other Assets | $13.00M | $16.63M | $17.80M |
YoY Change | -26.97% | -14.74% | -6.81% |
Total Long-Term Assets | $81.32M | $80.92M | $81.73M |
YoY Change | -0.5% | -4.09% | 2.36% |
TOTAL ASSETS | |||
Total Short-Term Assets | $114.3M | $108.6M | $103.6M |
Total Long-Term Assets | $81.32M | $80.92M | $81.73M |
Total Assets | $195.6M | $189.5M | $185.3M |
YoY Change | 5.58% | 5.13% | 8.24% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.011M | $1.866M | $1.776M |
YoY Change | -43.07% | -5.05% | 5.28% |
Accrued Expenses | $6.484M | $11.14M | $8.700M |
YoY Change | -25.47% | 3.18% | 16.0% |
Deferred Revenue | $15.00K | ||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $248.0K | $933.5K | $400.0K |
YoY Change | -38.0% | -4.14% | |
Total Short-Term Liabilities | $14.17M | $20.05M | $17.09M |
YoY Change | -17.11% | 7.42% | 14.78% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.061M | $1.809M | $1.900M |
YoY Change | -44.16% | -13.87% | 850.0% |
Other Long-Term Liabilities | $35.91M | $32.04M | $31.30M |
YoY Change | 14.73% | -2.91% | 3.64% |
Total Long-Term Liabilities | $37.21M | $34.09M | $33.37M |
YoY Change | 11.52% | -3.58% | 8.67% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $14.17M | $20.05M | $17.09M |
Total Long-Term Liabilities | $37.21M | $34.09M | $33.37M |
Total Liabilities | $51.38M | $54.14M | $50.46M |
YoY Change | 1.82% | 0.22% | 10.67% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$35.81M | -$46.01M | -$46.73M |
YoY Change | -23.37% | -18.16% | -17.72% |
Common Stock | $0.00 | $0.00 | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $675.0K | $675.0K | $675.0K |
YoY Change | 0.0% | -0.06% | |
Treasury Stock Shares | 12.00K shares | 12.00K shares | |
Shareholders Equity | $148.0M | $138.4M | $137.7M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $195.6M | $189.5M | $185.3M |
YoY Change | 5.61% | 5.13% | 8.22% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q2 | 2021 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $2.291M | $720.6K | $3.868M |
YoY Change | -40.77% | 24.24% | 206.74% |
Depreciation, Depletion And Amortization | $1.185M | $981.7K | $1.090M |
YoY Change | 8.72% | 7.88% | 9.22% |
Cash From Operating Activities | $4.322M | $5.948M | $3.590M |
YoY Change | 20.39% | -8.07% | -4.01% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.723M | -$646.8K | -$820.0K |
YoY Change | 110.12% | -32.62% | -58.16% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | -$2.800K | -$1.120M |
YoY Change | -100.0% | -107.34% | |
Cash From Investing Activities | -$1.723M | -$649.6K | -$1.940M |
YoY Change | -11.19% | -32.33% | -114.59% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -1.440M | -1.650M | -1.420M |
YoY Change | 1.41% | -689.41% | 0.0% |
NET CHANGE | |||
Cash From Operating Activities | 4.322M | 5.948M | 3.590M |
Cash From Investing Activities | -1.723M | -649.6K | -1.940M |
Cash From Financing Activities | -1.440M | -1.650M | -1.420M |
Net Change In Cash | 1.159M | 3.648M | 230.0K |
YoY Change | 403.91% | -36.99% | -98.53% |
FREE CASH FLOW | |||
Cash From Operating Activities | $4.322M | $5.948M | $3.590M |
Capital Expenditures | -$1.723M | -$646.8K | -$820.0K |
Free Cash Flow | $6.045M | $6.595M | $4.410M |
YoY Change | 37.07% | -11.24% | -22.63% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
usd | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000355019 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2022Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
usd | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6617000 | shares | |
CY2022Q1 | us-gaap |
Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
|
usd | |
CY2021Q2 | FONR |
Unearned Revenue On Service Contracts Related Parties
UnearnedRevenueOnServiceContractsRelatedParties
|
usd | |
CY2022Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
usd | |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
usd | |
CY2022Q1 | FONR |
Purchase Of Non Controlling Interest
PurchaseOfNonControllingInterest
|
usd | |
FONR |
Compensatory Element Of Stock Issuances
CompensatoryElementOfStockIssuances
|
usd | ||
FONR |
Stock Issued For Costs And Expenses
StockIssuedForCostsAndExpenses
|
usd | ||
us-gaap |
Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
|
usd | ||
FONR |
Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
|
usd | ||
us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
usd | ||
FONR |
Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
|
usd | ||
FONR |
Purchase Of Noncontrolling Interests
PurchaseOfNoncontrollingInterests
|
usd | ||
FONR |
Purchases Of Imaging Facility
PurchasesOfImagingFacility
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-03-31 | ||
dei |
Entity File Number
EntityFileNumber
|
0-10248 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
FONAR CORPORATION | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
11-2464137 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
110 Marcus Drive | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Melville | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
11747 | ||
dei |
City Area Code
CityAreaCode
|
(631) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
694-2929 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock | ||
dei |
Trading Symbol
TradingSymbol
|
FONR | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
CY2022Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
46010000 | usd |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
44460000 | usd |
CY2022Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
32000 | usd |
CY2021Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
32000 | usd |
CY2022Q1 | FONR |
Accounts Receivable Service And Repair Fees
AccountsReceivableServiceAndRepairFees
|
3943000 | usd |
CY2021Q2 | FONR |
Accounts Receivable Service And Repair Fees
AccountsReceivableServiceAndRepairFees
|
4526000 | usd |
CY2022Q1 | FONR |
Account Receivable Related Parties
AccountReceivableRelatedParties
|
30000 | usd |
CY2021Q2 | FONR |
Account Receivable Related Parties
AccountReceivableRelatedParties
|
12000 | usd |
CY2022Q1 | FONR |
Medical Receivable
MedicalReceivable
|
19548000 | usd |
CY2022Q1 | FONR |
Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
|
8489000 | usd |
CY2021Q2 | FONR |
Medical Receivable
MedicalReceivable
|
17901000 | usd |
CY2022Q1 | FONR |
Management And Other Fees
ManagementAndOtherFees
|
32804000 | usd |
CY2021Q2 | FONR |
Management And Other Fees
ManagementAndOtherFees
|
30948000 | usd |
CY2022Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2035000 | usd |
CY2021Q2 | FONR |
Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
|
7814000 | usd |
CY2022Q1 | us-gaap |
Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
|
15000 | usd |
CY2022Q1 | us-gaap |
Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
|
2368000 | usd |
CY2021Q2 | us-gaap |
Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
|
1663000 | usd |
CY2022Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1095000 | usd |
CY2021Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1227000 | usd |
CY2022Q1 | us-gaap |
Assets Current
AssetsCurrent
|
114334000 | usd |
CY2021Q2 | us-gaap |
Assets Current
AssetsCurrent
|
108583000 | usd |
CY2022Q1 | FONR |
Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
|
2066000 | usd |
CY2021Q2 | FONR |
Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
|
2880000 | usd |
CY2022Q1 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
12475000 | usd |
CY2021Q2 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
15959000 | usd |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
22441000 | usd |
CY2021Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
21850000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
34792000 | usd |
CY2021Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
30133000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
978000 | usd |
CY2021Q2 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
1127000 | usd |
CY2022Q1 | us-gaap |
Goodwill
Goodwill
|
4269000 | usd |
CY2021Q2 | us-gaap |
Goodwill
Goodwill
|
4269000 | usd |
CY2022Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3770000 | usd |
CY2021Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4038000 | usd |
CY2022Q1 | us-gaap |
Other Assets
OtherAssets
|
524000 | usd |
CY2021Q2 | us-gaap |
Other Assets
OtherAssets
|
667000 | usd |
CY2022Q1 | us-gaap |
Assets
Assets
|
195649000 | usd |
CY2021Q2 | us-gaap |
Assets
Assets
|
189506000 | usd |
CY2022Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
40000 | usd |
CY2021Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
173000 | usd |
CY2022Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1011000 | usd |
CY2021Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1866000 | usd |
CY2022Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
4916000 | usd |
CY2021Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
9162000 | usd |
CY2022Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
3869000 | usd |
CY2021Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
4366000 | usd |
CY2022Q1 | FONR |
Unearned Revenue On Service Contracts Related Parties
UnearnedRevenueOnServiceContractsRelatedParties
|
28000 | usd |
CY2021Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
15000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3733000 | usd |
CY2021Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3533000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
208000 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
203000 | usd |
CY2022Q1 | FONR |
Customer Deposits
CustomerDeposits
|
361000 | usd |
CY2021Q2 | FONR |
Customer Deposits
CustomerDeposits
|
731000 | usd |
CY2022Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14166000 | usd |
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
20049000 | usd |
CY2021Q1 | us-gaap |
Revenues
Revenues
|
23090000 | usd |
CY2022Q1 | us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
3306000 | usd |
CY2021Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2801000 | usd |
CY2022Q1 | us-gaap |
Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
|
238000 | usd |
CY2021Q2 | us-gaap |
Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
|
238000 | usd |
CY2022Q1 | us-gaap |
Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
|
93000 | usd |
CY2021Q2 | us-gaap |
Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
|
93000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
33659000 | usd |
CY2021Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
28975000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
892000 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
1049000 | usd |
CY2022Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
169000 | usd |
CY2021Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
760000 | usd |
CY2022Q1 | us-gaap |
Other Liabilities
OtherLiabilities
|
123000 | usd |
CY2021Q2 | us-gaap |
Other Liabilities
OtherLiabilities
|
171000 | usd |
CY2022Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
37209000 | usd |
CY2021Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
34087000 | usd |
CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
51375000 | usd |
CY2021Q2 | us-gaap |
Liabilities
Liabilities
|
54136000 | usd |
CY2022Q1 | FONR |
Commonstockvalue1
Commonstockvalue1
|
1000 | usd |
CY2021Q2 | FONR |
Commonstockvalue1
Commonstockvalue1
|
1000 | usd |
CY2022Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
184531000 | usd |
CY2021Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
185101000 | usd |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-35810000 | usd |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-46008000 | usd |
CY2022Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
12000 | shares |
CY2021Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
12000 | shares |
CY2022Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
675000 | usd |
CY2021Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
675000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
148047000 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
138419000 | usd |
CY2022Q1 | us-gaap |
Minority Interest
MinorityInterest
|
-3773000 | usd |
CY2021Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-3049000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
144274000 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
135370000 | usd |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
195649000 | usd |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
189506000 | usd |
CY2022Q1 | FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
|
7641000 | usd |
CY2021Q1 | FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
|
6043000 | usd |
CY2022Q1 | FONR |
Product Sales Net
ProductSalesNet
|
135000 | usd |
CY2021Q1 | FONR |
Product Sales Net
ProductSalesNet
|
503000 | usd |
CY2022Q1 | FONR |
Service And Repair Fees Net
ServiceAndRepairFeesNet
|
1876000 | usd |
CY2021Q1 | FONR |
Service And Repair Fees Net
ServiceAndRepairFeesNet
|
1914000 | usd |
CY2022Q1 | FONR |
Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
|
28000 | usd |
CY2021Q1 | FONR |
Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
|
28000 | usd |
CY2022Q1 | FONR |
Management And Other Fees Net
ManagementAndOtherFeesNet
|
11904000 | usd |
CY2021Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
18968000 | usd |
CY2021Q1 | FONR |
Management And Other Fees Net
ManagementAndOtherFeesNet
|
11808000 | usd |
CY2022Q1 | FONR |
Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
|
2987000 | usd |
CY2021Q1 | FONR |
Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
|
2794000 | usd |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
24571000 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
|
5638000 | usd |
CY2021Q1 | us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
2828000 | usd |
CY2022Q1 | FONR |
Costs Related To Product Sales
CostsRelatedToProductSales
|
53000 | usd |
CY2021Q1 | FONR |
Costs Related To Product Sales
CostsRelatedToProductSales
|
152000 | usd |
CY2022Q1 | FONR |
Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
|
747000 | usd |
CY2021Q1 | FONR |
Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
|
627000 | usd |
CY2022Q1 | FONR |
Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
|
11000 | usd |
CY2021Q1 | FONR |
Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
|
9000 | usd |
CY2022Q1 | FONR |
Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
|
6696000 | usd |
CY2021Q1 | FONR |
Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
|
7073000 | usd |
CY2022Q1 | FONR |
Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
|
1698000 | usd |
CY2021Q1 | FONR |
Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
|
1746000 | usd |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
354000 | usd |
CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
419000 | usd |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6068000 | usd |
CY2021Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6114000 | usd |
CY2022Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
18933000 | usd |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
|
4122000 | usd |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
144000 | usd |
CY2022Q1 | FONR |
Interest Expenses
InterestExpenses
|
-31000 | usd |
CY2021Q1 | FONR |
Interest Expenses
InterestExpenses
|
19000 | usd |
CY2022Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
58000 | usd |
CY2021Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
64000 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
5727000 | usd |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
4311000 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2465000 | usd |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
12000 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
3262000 | usd |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
4299000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
971000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
431000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2291000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3868000 | usd |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.33 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.55 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.32 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.54 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6682000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6682000 | shares |
FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
|
21935000 | usd | |
FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
|
16372000 | usd | |
FONR |
Product Sales Net
ProductSalesNet
|
481000 | usd | |
FONR |
Product Sales Net
ProductSalesNet
|
534000 | usd | |
FONR |
Service And Repair Fees Net
ServiceAndRepairFeesNet
|
5720000 | usd | |
FONR |
Service And Repair Fees Net
ServiceAndRepairFeesNet
|
5702000 | usd | |
FONR |
Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
|
18861000 | usd | |
FONR |
Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
|
5024000 | usd | |
FONR |
Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
|
83000 | usd | |
FONR |
Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
|
83000 | usd | |
FONR |
Management And Other Fees Net
ManagementAndOtherFeesNet
|
35985000 | usd | |
FONR |
Management And Other Fees Net
ManagementAndOtherFeesNet
|
34362000 | usd | |
FONR |
Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
|
8576000 | usd | |
FONR |
Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
|
8181000 | usd | |
us-gaap |
Revenues
Revenues
|
72780000 | usd | |
us-gaap |
Revenues
Revenues
|
65234000 | usd | |
us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
9785000 | usd | |
us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
7997000 | usd | |
FONR |
Costs Related To Product Sales
CostsRelatedToProductSales
|
352000 | usd | |
FONR |
Costs Related To Product Sales
CostsRelatedToProductSales
|
477000 | usd | |
FONR |
Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
|
2190000 | usd | |
FONR |
Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
|
1861000 | usd | |
FONR |
Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
|
32000 | usd | |
FONR |
Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
|
27000 | usd | |
FONR |
Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
|
20497000 | usd | |
FONR |
Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
|
4696000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1109000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1243000 | usd | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
15928000 | usd | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
16818000 | usd | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
54917000 | usd | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
51980000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
|
17863000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
|
13254000 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
858000 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
4000 | usd | |
FONR |
Interest Expenses
InterestExpenses
|
9000 | usd | |
FONR |
Interest Expenses
InterestExpenses
|
57000 | usd | |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
180000 | usd | |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
251000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
18892000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
13452000 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5311000 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1974000 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
13581000 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
11478000 | usd | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
3383000 | usd | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
1991000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
10198000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
9487000 | usd | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.46 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.37 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.43 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.35 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6682000 | shares | |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
142442000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2291000 | usd |
CY2022Q1 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
1430000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
971000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
144274000 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
131876000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3868000 | usd |
CY2021Q1 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
1380000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
431000 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
134795000 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
135370000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
10198000 | usd | |
FONR |
Purchase Of Non Controlling Interest
PurchaseOfNonControllingInterest
|
-546000 | usd | |
us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
4131000 | usd | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
3383000 | usd | |
CY2022Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
144274000 | usd |
CY2020Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
126242000 | usd |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2025000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
9487000 | usd | |
us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
4950000 | usd | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
1991000 | usd | |
CY2021Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
134795000 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
13581000 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
11478000 | usd | |
us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
3543000 | usd | |
us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
3100000 | usd | |
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
2953000 | usd | |
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
1543000 | usd | |
FONR |
Provision For Bad Debts
ProvisionForBadDebts
|
2150000 | usd | |
FONR |
Provision For Bad Debts
ProvisionForBadDebts
|
5103000 | usd | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
3484000 | usd | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1712000 | usd | |
FONR |
Compensatory Element Of Stock Issuances
CompensatoryElementOfStockIssuances
|
83000 | usd | |
FONR |
Stock Issued For Costs And Expenses
StockIssuedForCostsAndExpenses
|
1941000 | usd | |
us-gaap |
Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
|
-1000 | usd | |
FONR |
Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
|
701000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4950000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9551000 | usd | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-32000 | usd | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-36000 | usd | |
us-gaap |
Increase Decrease In Commodity Contract Assets And Liabilities
IncreaseDecreaseInCommodityContractAssetsAndLiabilities
|
15000 | usd | |
us-gaap |
Increase Decrease In Commodity Contract Assets And Liabilities
IncreaseDecreaseInCommodityContractAssetsAndLiabilities
|
65000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
705000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
323000 | usd | |
us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
671000 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-112000 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-424000 | usd | |
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-132000 | usd | |
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-855000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-189000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-5480000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-1827000 | usd | |
us-gaap |
Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
|
-2579000 | usd | |
us-gaap |
Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
|
-1168000 | usd | |
FONR |
Increase Decrease In Financing Liabilities
IncreaseDecreaseInFinancingLiabilities
|
151000 | usd | |
FONR |
Increase Decrease In Financing Liabilities
IncreaseDecreaseInFinancingLiabilities
|
25000 | usd | |
FONR |
Increase Decrease In Customer Advance
IncreaseDecreaseInCustomerAdvance
|
-370000 | usd | |
FONR |
Increase Decrease In Customer Advance
IncreaseDecreaseInCustomerAdvance
|
183000 | usd | |
FONR |
Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
|
15000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-49000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
14000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
10117000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
13140000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3807000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2942000 | usd | |
FONR |
Purchase Of Noncontrolling Interests
PurchaseOfNoncontrollingInterests
|
546000 | usd | |
FONR |
Purchases Of Imaging Facility
PurchasesOfImagingFacility
|
1123000 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
60000 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
108000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4413000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4173000 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
23000 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
73000 | usd | |
us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
63000 | usd | |
us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
4131000 | usd | |
us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
4950000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4154000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4960000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
1550000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
4007000 | usd | |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
44460000 | usd |
CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
36802000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
46010000 | usd |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
40809000 | usd |
CY2022Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
128000 | shares |
CY2021Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
128000 | shares |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
128000 | shares | |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
128000 | shares | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2291000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3868000 | usd |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6554000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6554000 | shares |
CY2022Q1 | FONR |
Earnings Per Share Basics
EarningsPerShareBasics
|
0.35 | |
CY2021Q1 | FONR |
Earnings Per Share Basics
EarningsPerShareBasics
|
0.59 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
10198000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
9487000 | usd | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6554000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6489000 | shares | |
FONR |
Earnings Per Share Basics
EarningsPerShareBasics
|
1.56 | ||
FONR |
Earnings Per Share Basics
EarningsPerShareBasics
|
1.46 | ||
CY2022Q1 | FONR |
Accounts Receivable Service And Repair Fees
AccountsReceivableServiceAndRepairFees
|
3943000 | usd |
CY2022Q1 | FONR |
Accounts Receivable Net Related Party
AccountsReceivableNetRelatedParty
|
30000 | usd |
CY2022Q1 | FONR |
Medical Receivable
MedicalReceivable
|
19548000 | usd |
CY2022Q1 | FONR |
Management And Other Fees Non Related Parties
ManagementAndOtherFees_NonRelatedParties
|
32804000 | usd |
CY2022Q1 | FONR |
Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
|
8489000 | usd |
CY2021Q2 | FONR |
Accounts Receivable Service And Repair Fees
AccountsReceivableServiceAndRepairFees
|
4526000 | usd |
CY2021Q2 | FONR |
Accounts Receivable Net Related Party
AccountsReceivableNetRelatedParty
|
12000 | usd |
CY2021Q2 | FONR |
Medical Receivable
MedicalReceivable
|
17901000 | usd |
CY2021Q2 | FONR |
Management And Other Fees Non Related Parties
ManagementAndOtherFees_NonRelatedParties
|
30948000 | usd |
CY2021Q2 | FONR |
Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
|
7814000 | usd |
CY2022Q1 | us-gaap |
Contract Receivable Due One To Two Years
ContractReceivableDueOneToTwoYears
|
1020000 | usd |
CY2022Q1 | us-gaap |
Contract Receivable Due Two To Three Years
ContractReceivableDueTwoToThreeYears
|
793000 | usd |
CY2022Q1 | us-gaap |
Contract Receivable Due Three To Four Years
ContractReceivableDueThreeToFourYears
|
216000 | usd |
CY2022Q1 | us-gaap |
Contract Receivable Due Four To Five Years
ContractReceivableDueFourToFiveYears
|
6000 | usd |
CY2022Q1 | us-gaap |
Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
|
2035000 | usd |
CY2022Q1 | FONR |
Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims
PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
|
0.666 | pure |
CY2021Q1 | FONR |
Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims
PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
|
0.645 | pure |
FONR |
Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims
PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
|
0.666 | pure | |
FONR |
Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims
PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
|
0.654 | pure | |
CY2022Q1 | FONR |
Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
|
0.122 | pure |
CY2021Q1 | FONR |
Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
|
0.121 | pure |
FONR |
Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
|
0.118 | pure | |
FONR |
Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
|
0.125 | pure | |
CY2022Q1 | FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discount
PatientFeeRevenueNetOfContractualAllowancesAndDiscount
|
7641000 | usd |
CY2021Q1 | FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discount
PatientFeeRevenueNetOfContractualAllowancesAndDiscount
|
6043000 | usd |
FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discount
PatientFeeRevenueNetOfContractualAllowancesAndDiscount
|
21935000 | usd | |
FONR |
Patient Fee Revenue Net Of Contractual Allowances And Discount
PatientFeeRevenueNetOfContractualAllowancesAndDiscount
|
16372000 | usd | |
CY2019Q3 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
33300000 | usd |
CY2022Q1 | us-gaap |
Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
|
2368000 | usd |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
5397000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
244000 | usd |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
5352000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
244000 | usd |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
5212000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
244000 | usd |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
4850000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
244000 | usd |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
4013000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
225000 | usd |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
23223000 | usd |
CY2022Q1 | FONR |
Present Value Discount
PresentValueDiscount
|
-10655000 | usd |
CY2022Q1 | FONR |
Present Value Discount Financing Lease
PresentValueDiscountFinancingLease
|
-101000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
37392000 | usd |
CY2022Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
1100000 | usd |
CY2022Q1 | us-gaap |
Other Inventory Supplies
OtherInventorySupplies
|
2259000 | usd |
CY2021Q2 | us-gaap |
Other Inventory Supplies
OtherInventorySupplies
|
1393000 | usd |
CY2022Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
109000 | usd |
CY2021Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
270000 | usd |
CY2022Q1 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
2256000 | usd |
CY2021Q2 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
5407000 | usd |
CY2021Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
900000 | usd |
CY2022Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
275000 | usd |
CY2021Q2 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
645000 | usd |
CY2022Q1 | FONR |
State Income Taxes Payable
StateIncomeTaxesPayable
|
1074000 | usd |
CY2021Q2 | us-gaap |
Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
|
1663000 | usd |
CY2022Q1 | FONR |
Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
|
397000 | usd |
CY2021Q2 | FONR |
Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
|
295000 | usd |
CY2022Q1 | FONR |
Estimated Earnings
EstimatedEarnings
|
496000 | usd |
CY2021Q2 | FONR |
Estimated Earnings
EstimatedEarnings
|
568000 | usd |
CY2022Q1 | FONR |
Costs And Estimated Earnings On Uncompleted Contracts
CostsAndEstimatedEarningsOnUncompletedContracts
|
893000 | usd |
CY2021Q2 | FONR |
Costs And Estimated Earnings On Uncompleted Contracts
CostsAndEstimatedEarningsOnUncompletedContracts
|
863000 | usd |
CY2022Q1 | FONR |
Billings To Date
BillingsToDate
|
878000 | usd |
CY2021Q2 | FONR |
Billings To Date
BillingsToDate
|
878000 | usd |
CY2022Q1 | FONR |
Total Costs And Estimated Earnings In Excess Of Billings On Uncompleted Contracts Net
TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet
|
15000 | usd |
CY2021Q2 | FONR |
Total Costs And Estimated Earnings In Excess Of Billings On Uncompleted Contracts Net
TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet
|
-15000 | usd |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
20360000 | usd |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
20300000 | usd |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
16590000 | usd |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
16262000 | usd |
CY2022Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3770000 | usd |
CY2021Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4038000 | usd |
CY2021Q2 | FONR |
State Income Taxes Payable
StateIncomeTaxesPayable
|
774000 | usd |
CY2022Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
15000 | usd |
CY2021Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
38000 | usd |
CY2022Q1 | us-gaap |
Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
|
146000 | usd |
CY2021Q2 | us-gaap |
Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
|
127000 | usd |
CY2022Q1 | us-gaap |
Self Insurance Reserve
SelfInsuranceReserve
|
32000 | usd |
FONR |
Litigation Settelement Description
LitigationSettelementDescription
|
In September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The settlement was for $1,200 of which $900 was paid by the Company’s insurance in September 2020. The Company paid the remaining balance of $315 in September 2020. | ||
CY2021Q2 | us-gaap |
Self Insurance Reserve
SelfInsuranceReserve
|
62000 | usd |
CY2022Q1 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
59000 | usd |
CY2021Q2 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
493000 | usd |
CY2022Q1 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
1059000 | usd |
CY2021Q2 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
716000 | usd |
CY2022Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
4916000 | usd |
CY2021Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
9162000 | usd |
CY2022Q1 | FONR |
Net Revenues From External Customers
NetRevenuesFromExternalCustomers
|
24571000 | usd |
CY2022Q1 | FONR |
Intersegment Net Revenues
IntersegmentNetRevenues
|
245000 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
5638000 | usd |
CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1185000 | usd |
CY2022Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1663000 | usd |
CY2021Q1 | FONR |
Net Revenues From External Customers
NetRevenuesFromExternalCustomers
|
23090000 | usd |
CY2021Q1 | FONR |
Intersegment Net Revenues
IntersegmentNetRevenues
|
227000 | usd |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
4122000 | usd |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1090000 | usd |
CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
817000 | usd |
FONR |
Net Revenues From External Customers
NetRevenuesFromExternalCustomers
|
72780000 | usd | |
FONR |
Intersegment Net Revenues
IntersegmentNetRevenues
|
720000 | usd | |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
17863000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3543000 | usd | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
3807000 | usd | |
FONR |
Net Revenues From External Customers
NetRevenuesFromExternalCustomers
|
65234000 | usd | |
FONR |
Intersegment Net Revenues
IntersegmentNetRevenues
|
665000 | usd | |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
13254000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3100000 | usd | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
3050000 | usd | |
us-gaap |
Interest Paid
InterestPaid
|
279000 | usd | |
us-gaap |
Interest Paid
InterestPaid
|
55000 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1105000 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
261000 | usd | |
CY2022Q1 | FONR |
Maximum Limit For Individual Claims Under Stoploss Umbrella Policy For Health Insurance
MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance
|
150000 | usd |
CY2022Q1 | us-gaap |
Self Insurance Reserve
SelfInsuranceReserve
|
32000 | usd |
CY2021Q2 | us-gaap |
Self Insurance Reserve
SelfInsuranceReserve
|
62000 | usd |
us-gaap |
Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
|
5311000 | usd | |
us-gaap |
Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
|
1974000 | usd | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
1827000 | usd | |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
3484000 | usd | |
CY2022Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
12475000 | usd |
CY2022Q1 | us-gaap |
Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
|
238000 | usd |
CY2022Q1 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
20877000 | usd |
FONR |
Reimbursement Of Alternative Minimum Tax Credits Description
ReimbursementOfAlternativeMinimumTaxCreditsDescription
|
At the present time, the only impact of the CARES Act to the Company is allowing a full reimbursement of $1,342 of tax credits relating to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum tax credits of $671 was received in July 2020. Previously, these credits were to be refunded over a 3 year period. | ||
CY2021Q1 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
550000 | usd |
CY2021Q1 | FONR |
Diagnostic Equipment
DiagnosticEquipment
|
100000 | usd |
CY2021Q1 | us-gaap |
Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
|
100000 | usd |
CY2021Q1 | FONR |
Covenant Not To Compete
CovenantNotToCompete
|
50000 | usd |
CY2021Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
39000 | usd |
CY2021Q1 | FONR |
Closing Costs Expensed
ClosingCostsExpensed
|
3000 | usd |
CY2021Q1 | FONR |
Net Goodwill
NetGoodwill
|
284000 | usd |
CY2021Q1 | FONR |
Business Combination Consideration Transferred Other
BusinessCombinationConsiderationTransferredOther
|
1126000 | usd |